Recent Immunoglobulin G1 Engineering Strategies to Modulate Immune Effector Functions for Therapeutics

Clicks: 17
ID: 332270
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #51 of 72 articles by views in glycobiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract IgG is the most common scaffold used for antibody-based therapeutics. Utilization of the ever-expanding knowledge base of the IgG scaffold provides a wealth of design options for therapeutic development. These therapeutics apply varied engineering strategies in various combinations utilizing three key IgG features: the crystallizable fragment (Fc), antigen-binding fragment (Fab), and the conserved N-glycans. Designs may be as simple as amino acid variants to modulate effector function or as complex as large designs incorporating additional Fab, Fc, and non-IgG domain fusions to modulate effector molecule recognition, valency, and antigen specificity. The engineering strategies and basic knowledge supporting these developments have been the subject of rapid expansion. Here we review multiple approaches and advances with a focus on the last five years.
Reference Key
openalex_W7221685306 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alexander R. Davis, Adam W. Barb
Journal glycobiology
Year 2026
DOI
10.1093/glycob/cwag098
URL
https://doi.org/10.1093/glycob/cwag098
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.